Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Contract Wins and Covid Business Interruption Loan

5 Feb 2021 07:00

RNS Number : 0828O
Falanx Group Limited
05 February 2021
 

5 February 2021

FALANX GROUP LIMITED

("Falanx", the "Group" or the "Company")

Contract Wins and Coronavirus Business Interruption Loan 

Falanx Group Limited (FLX.L), the AIM listed provider of cyber security and strategic intelligence services, announces new contract wins and renewals alongside discussions in relation to the UK government backed Coronavirus Business Interruption Loan ("CBIL").

 Cyber Security Division

 

The division has since November 2020 signed a further five new customers as well as an expansion to some existing contracts for Triarii, its enhanced cyber security monitoring service. The new customers span a range of sectors, namely charity, financial services, pharma, defence and IT - clearly illustrating the universal appeal of the Triarii offering. This has been achieved through a combination of direct and indirect sales including the SolarWinds and Trustmarque partnerships. In terms of service coverage, they include Triarii MDR, Managed EDR and Triarii for Sentinel - the Microsoft Azure-based service which was launched on 13 January 2021 and which was developed in partnership with Trustmarque, part of Capita plc. Further details are on https://www.trustmarque.com/cyber-security/managed-detection-and-response-service/

 

The division has also maintained the strong performance of its penetration testing business, and this is materially above the pre-COVID-19 sales order run rate achieved this time last year. Clients are from several sectors including insurance and construction, with one client signing a three year framework agreement worth approximately £180,000 in total.

 

In total the order value across all of these contracts is in excess of £700,000, of which approximately £400,000 will benefit the 2021 calendar year. The order pipeline remains strong with similar prospective sales for both penetration testing and security monitoring.

 

 

Assynt Strategic Intelligence Division

 

The division has continued with its solid profitable performance which remains in line with management expectations. It has recently received a renewal for the provision of analysts from an existing client, one of the world's largest technology companies, for £1.2m spread over the next three financial years. Further significant cyclical contract renewals from major corporations are expected to be received in the next few months, and it has a robust pipeline of opportunities from new and existing customers.

 

Potential Coronavirus Business Interruption Loan ("CBIL") and Capital Reconstruction.

 

Falanx announces that it is in discussions with a specialist lender for the provision of a UK Government backed CBIL loan. This loan would enable the Group to make earnings enhancing acquisitions to enhance its core Cyber division, as well as supporting organic growth. To qualify for the CBIL the Company will be carrying out a capital reconstruction by reducing the share premium account, to decrease the deficit on retained earnings. The reduction of the deficit on retained earnings will, amongst other things, facilitate Falanx in making distributions to its shareholders at some point in the future. Under BVI law the reconstruction will require a change to the memorandum and articles of association and a general meeting will shortly be called in respect of this proposal.

 

Mike Read, Chief Executive, commented: "I am pleased with the continued contract momentum in both of our divisions. Triarii is gaining further traction and recent sales of, and interest in, our Microsoft Sentinel service offering, which was only launched last month, validates our chosen strategy of channel partners and using third party leading technologies to deliver our services. Customers in both divisions are increasing their commitments to us in terms of both quantum and duration and again, this underlies the value of our services to them. We will look to progress the CBIL opportunity and will update the market at the appropriate time as we see this as a strategy which can further support equity growth by enabling earnings enhancing acqusitions."

 

Enquiries:

 

Falanx Group Limited

Alex Hambro Chairman

Mike Read CEO

Ian Selby CFO

 

Via IFC

Stifel Nicolaus Europe Limited, Nomad and Joint Broker

Alex Price / Fred Walsh

+ 44 (0) 207 710 7600

 

IFC Advisory Ltd, Financial PR & IR

Graham Herring / Zach Cohen

 

+44 (0) 203 934 663

 

 

About Falanx

Falanx Group Limited, is a global intelligence and cyber defence provider working with blue chip and government clients. For more information: https://www.falanx.com/

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCTIMLTMTJMBIB
Date   Source Headline
9th Dec 20222:42 pmRNSHolding(s) in Company
8th Dec 20224:29 pmRNSResult of AGM
8th Dec 20227:00 amRNSInterim Results
24th Nov 20225:17 pmRNSHolding(s) in Company
15th Nov 20225:56 pmRNSNotice of AGM
18th Oct 20227:00 amRNSDirectorate Change
29th Sep 20227:00 amRNSFinal Results
20th Sep 20227:00 amRNSHolding(s) in Company
5th Sep 20224:53 pmRNSHolding(s) in Company
4th Aug 20222:06 pmRNSSecond Price Monitoring Extn
4th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 202211:05 amRNSSecond Price Monitoring Extn
4th Aug 202211:00 amRNSPrice Monitoring Extension
4th Aug 20227:00 amRNSTrading Update
9th May 20227:00 amRNSPartnership to Provide M-EDR to UK Customers
8th Apr 20224:06 pmRNSHolding(s) in Company
6th Apr 202211:59 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSChange of Adviser
30th Mar 20222:44 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:59 pmRNSDirector/PDMR Shareholding
10th Feb 202211:11 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20225:20 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 202111:14 amRNSResult of AGM
7th Dec 20217:00 amRNSInterim Results
16th Nov 20212:10 pmRNSNotice of AGM
29th Oct 20211:57 pmRNSExercise of Options, TVR and PDMR dealing
27th Oct 20219:03 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSDirector/PDMR Shareholding
25th Oct 20213:25 pmRNSExercise of Options and TVR
13th Oct 202111:06 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSTrading update and BOOST&Co loan facility update
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:43 pmRNSSale of Assynt for £4.6 million
4th Oct 20217:00 amRNSFalanx Launch Mass Market Security Assessment Tool
29th Sep 20217:00 amRNSAnnual results for the year ended 31 March 2021
18th Aug 20217:01 amRNSGrant of share options
18th Aug 20217:00 amRNSTrading Update & New Loan Facility
9th Jul 20219:07 amRNSHolding(s) in Company
29th Apr 20217:00 amRNSCancellation of unapproved Share Options
1st Apr 20217:00 amRNSIssue of Equity and TVR
26th Feb 20213:31 pmRNSResult of GM
10th Feb 20212:03 pmRNSPublication of Circular & Notice of GM
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSContract Wins and Covid Business Interruption Loan
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.